Aescuvest
Aescuvest, founded in 2014 and based in Frankfurt, Germany, is a venture capital firm focused on the healthcare sector. Its mission is to facilitate impactful investments in medical innovations that aim to enhance healthcare delivery, products, and services. Aescuvest enables investors to create personalized portfolios of healthcare start-ups tailored to their investment interests. Through collaborations with EIT Health and a growing network of partnerships across Europe, the firm identifies and evaluates promising healthcare investment opportunities. Aescuvest employs a robust pre-screening and due diligence process, managed by an experienced Investment Committee comprised of its investment team and advisory board members with strong backgrounds in the healthcare industry. The firm's general partners actively invest their own capital in each venture, ensuring alignment of interests with their investors. By combining innovative equity capital solutions with healthcare expertise, Aescuvest offers a unique platform that helps portfolio companies develop their business solutions, accelerate commercialization, and overcome market access challenges.
Top Stages
23 past transactions
XO Life
Venture Round in 2024
XO Life operates a digital platform that facilitates patient education, engagement, and monitoring. It offers services such as real-time treatment tracking, patient feedback analysis, and insights exchange between patients and pharmaceutical companies. The platform aims to enhance medication adherence, improve patient outcomes, and foster better communication between patients and healthcare providers.
Neteera
Series B in 2023
Neteera is a technology company focused on remote contactless sensing, providing continuous and non-invasive monitoring of human vital signs. Utilizing a micro-radar on chip and proprietary algorithms, Neteera's technology detects microscopic skin motions, allowing it to monitor vital signs such as heart rate, respiration rate, and other physiological parameters without direct contact. This innovative approach leverages the detection of electromagnetic emissions from sweat ducts, enabling safe and cost-effective biometric identification and continuous monitoring. By bridging the gap between the analog and digital worlds, Neteera aims to enhance the ease and effectiveness of health monitoring in various settings.
Lillian Care
Pre Seed Round in 2023
Lillian is building a nationwide network of health facilities in Germany.
Neteera
Series B in 2023
Neteera is a technology company focused on remote contactless sensing, providing continuous and non-invasive monitoring of human vital signs. Utilizing a micro-radar on chip and proprietary algorithms, Neteera's technology detects microscopic skin motions, allowing it to monitor vital signs such as heart rate, respiration rate, and other physiological parameters without direct contact. This innovative approach leverages the detection of electromagnetic emissions from sweat ducts, enabling safe and cost-effective biometric identification and continuous monitoring. By bridging the gap between the analog and digital worlds, Neteera aims to enhance the ease and effectiveness of health monitoring in various settings.
Piur Imaging
Series A in 2023
Piur Imaging GmbH, founded in 2014 and based in Vienna, Austria, specializes in the development of advanced tomographic ultrasound technology aimed at enhancing vascular imaging. The company manufactures the PIUR tomographic ultrasound equipment, which transforms standard ultrasound systems into high-resolution 3D imaging devices, enabling improved diagnostic capabilities. Their product line includes applications for endovascular aneurysm repair (EVAR) surveillance, carotid angiography, and 3D vascular mapping, all of which enhance the detection and classification of vascular conditions. The technology is designed to reduce operator dependency and optimize diagnostic workflows, providing safer and more affordable imaging solutions. Additionally, Piur Imaging is focusing on thyroid imaging, utilizing AI algorithms to facilitate rapid and objective analysis of thyroid nodules, thereby improving diagnostic efficiency.
XO Life
Seed Round in 2022
XO Life operates a digital platform that facilitates patient education, engagement, and monitoring. It offers services such as real-time treatment tracking, patient feedback analysis, and insights exchange between patients and pharmaceutical companies. The platform aims to enhance medication adherence, improve patient outcomes, and foster better communication between patients and healthcare providers.
Medikura
Seed Round in 2022
MEDIKURA Digital Health GmbH, founded in 2017 and based in Munich, Germany, specializes in developing a platform focused on drug safety issues and analysis. The company offers a suite of products, including MEDIKURA Capture, which allows users to report side effects online; MEDIKURA Insights, which provides insights into drug safety and customer satisfaction; and MEDIKURA Guide, designed to help users understand the risks and benefits of their medications. Catering primarily to the pharmaceutical and insurance industries, MEDIKURA aims to enhance drug safety and improve the overall understanding of medication-related risks.
Munevo
Equity Crowdfunding in 2020
Munevo GmbH, founded in 2011 and based in Nuremberg, Germany, specializes in developing innovative technology to enhance mobility for individuals with disabilities. The company's flagship product, munevo DRIVE, is a Smartglass application designed to control electric wheelchairs through the user's head movements, allowing for hands-free operation. This technology enables users to navigate both indoors and outdoors, promoting greater independence and mobility. In addition to its core product, Munevo also provides adaptors and accessories to support its solutions, further empowering individuals with mobility impairments.
Emperra
Equity Crowdfunding in 2020
Emperra E-Health Technologies is a German company based in Potsdam, established in 2008, that specializes in the development of telemedical products aimed at managing diabetes. The company focuses on creating GSM and web-based systems for tracking, monitoring, and transmitting crucial diagnostic and therapeutic data related to diabetes. Its innovative diabetes monitoring solutions include a Bluetooth-enabled insulin pen and a wireless blood glucose meter, which allow healthcare professionals to effectively monitor insulin doses, blood sugar levels, and carbohydrate intake in patients. By facilitating real-time data transmission, Emperra enhances the ability of doctors and nurses to manage diabetes care efficiently.
Lipozyt Marker
Equity Crowdfunding in 2020
Lipozyt Marker provides oral anti-diabetic therapy. They offer a test kit that conducts mRNA analysis of the subcutaneous fatty tissue in combination with classic blood tests to determine individual causes of diabetes.
BOCAhealthcare GmbH
Equity Crowdfunding in 2020
BOCAhealth is a patented portable device (connected to an app) that is able to measure and keep track of the hydration status of a user without the need for medical personnel.
Surge-on Medical
Equity Crowdfunding in 2019
Surge-On Medical specializes in the development of innovative surgical instruments, focusing on minimally invasive techniques for arthroscopy and laparoscopy. The company designs steerable, detachable, and cleanable instruments that enhance instrument reachability and facilitate easier cleaning, ultimately improving surgical procedures. By providing surgeons with better access to challenging surgical areas, Surge-On Medical aims to elevate the standards of minimally invasive surgery.
faber Biomechanik GmbH
Equity Crowdfunding in 2019
Adiuvad offers services for both in-clinic and home rehabilitation as it includes gait training. They provide a therapy device that allows the patient to get into the device from a wheelchair or bed and do walking exercises and interrupt the exercise.
Medivid GmbH
Equity Crowdfunding in 2019
Medivid is a cooling therapy for tendons, ligaments, muscles, and joints. Their therapy set contains the ingredients needed to start with consistent cooling therapy for symptoms.
MediTip-Medical MTM
Equity Crowdfunding in 2018
MediTip-Medical MTM GmbH specializes in the supply of disposable medical instruments and treatment units for healthcare providers, including doctors and hospitals. The company offers a diverse range of sterile, single-use products such as clamps, dental sets, needle holders, tweezers, spatulas, and spoons, all manufactured under stringent quality management standards tailored for medical devices. By focusing on single-use healthcare solutions, MediTip-Medical MTM aims to minimize the risk of cross-contamination and infections, thereby enhancing patient safety and operational efficiency for its clients.
Check-Up Scout GmbH
Equity Crowdfunding in 2018
Check-Up Scout provides health prevention and evidence-based medicine and self-learning processes. Additionally, they also provide health care more individuals and health care software applications.
VisionHealth
Equity Crowdfunding in 2018
VisionHealth GmbH is a healthcare software company based in Munich, Germany, founded in 2017. It specializes in developing digital solutions for patients with chronic respiratory diseases, such as asthma and COPD. The company's primary product, Kata, is an artificial intelligence and machine learning-based application that connects respiratory patients with healthcare professionals. Kata enhances inhalation therapy by training patients on the effective use of their inhalers, utilizing advanced object recognition and movement interpretation technologies. This innovative approach aims to improve patient adherence to inhalation therapy, ultimately reducing hospital visits and lowering overall therapy costs for chronic lung conditions.
MOIO GmbH
Equity Crowdfunding in 2017
MOIO GmbH, founded in 2017 and headquartered in Fürth, Germany, is a digital health startup focused on developing innovative solutions for the healthcare market. The company's flagship product, the moio.care system, is a sensor-based wearable device designed to enhance patient care. This smart care patch can be worn on the skin using various application methods, including an adhesive strip or a glueless ribbon. The device tracks user movement and is capable of alerting caregivers when a disoriented individual leaves a designated area or when a fall occurs, thereby improving safety and response times. MOIO GmbH aims to continuously refine and expand its offerings through collaborations with partners in research and industry.
epinamics
Equity Crowdfunding in 2017
Epinamics is a pharmaceutical research and development company specializing in innovative drug delivery solutions. The firm focuses on developing advanced therapeutic pumps that facilitate superficial delivery of medicinal drugs. Epinamics employs a polymer-based, sprayable, and film-forming technology designed for dermal and transdermal applications, allowing patients to utilize pharmaceutical ingredients effectively in high concentrations and low volumes. With expertise in bringing medical products to market swiftly, Epinamics supports both the development of novel pharmaceutical ingredients and the enhancement of existing products, ensuring their innovative technologies reach retail shelves efficiently.
Rodos BioTarget
Equity Crowdfunding in 2017
Rodos BioTarget GmbH, established in 2008 and headquartered in Hanover, Germany, is a biopharmaceutical company specializing in the development of targeted drug delivery systems using nanotechnology. The company's flagship product, TargoSphere®, is a patented nanocarrier platform designed to selectively deliver therapeutic agents directly into antigen-presenting cells. This technology has shown promise in various infectious disease models caused by viruses such as HCV and HIV, and bacteria like MRSA. Rodos BioTarget aims to expand its applications to other disorders involving immune response dysregulation, including chronic inflammations, cancers, allergies, and autoimmune diseases.
ImmunoLogik
Equity Crowdfunding in 2017
ImmunoLogik is a biotechnology company engaged in the discovery, development, and commercialization of innovative antiviral drugs aimed at treating viral infections, including those caused by HIV and SARS-CoV-2. The company focuses on creating therapies that address both congenital and acquired immune system disorders, providing effective treatment options for HIV-positive patients. Additionally, ImmunoLogik has developed a broad-spectrum antiviral drug specifically designed for the treatment of patients infected with SARS-CoV-2, demonstrating its commitment to addressing current and future coronavirus infections. Through its advanced drug development services, ImmunoLogik aims to enhance the capabilities of healthcare professionals in managing viral diseases.
nice!innovations
Equity Crowdfunding in 2015
nice! innovations GmbH is developing a new type of external fixator system - the so-called "snakeFX".
Activoris Medizintechnik GmbH
Equity Crowdfunding in 2015
Med-Tech and pharma specialist
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.